COMMUNIQUÉS West-GlobeNewswire

Amedisys Reports Third Quarter 2017 Financial Results
07/11/2017
BATON ROUGE, La., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three and nine-month periods ended September 30, 2017. Three Month Periods Ended September [...]
Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
07/11/2017
BURNABY, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today reported its financial results for the quarter ended September [...]
Profound Medical Corp. Announces Third Quarter 2017 Financial Results
07/11/2017
TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights
07/11/2017
-- Phase III ADVOCATE trial of avacopan remains on track to complete enrollment in mid-2018 -- -- Patient enrollment ongoing in registration-supporting trial for avacopan in the treatment C3 Glomerulopathy (C3G) -- -- [...]
Alder BioPharmaceuticals® Announces Third Quarter 2017 Financial and Operating Results
07/11/2017
– PROMISE 2 pivotal trial completed enrollment and top-line data on track for 1H18 – – Eptinezumab Biologics License Application (BLA) submission on track for 2H18 – – Conference call scheduled for 5 p.m. ET today – [...]
REVA Medical Reports Third Quarter 2017 Financial Results
07/11/2017
SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported financial results for [...]
Akcea to Present at Stifel 2017 Healthcare Conference
07/11/2017
CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
07/11/2017
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings
07/11/2017
Revenue increased 307% and 87%, respectively, compared to the three and nine month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz., Nov. 07, 2017 (GLOBE NEWSWIRE [...]
Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
07/11/2017
AUSTIN, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ: AGLE ) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat [...]
Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference
07/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the Stifel 2017 Healthcare Conference in New York City on [...]
Novavax Reports Third Quarter 2017 Financial Results
07/11/2017
GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced its financial results for the third quarter and nine months ended September 30, 2017. Third Quarter Achievements: [...]
Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results
07/11/2017
Total Revenues of $190.2 Million Up 7 Percent GAAP Diluted EPS of $1.15 and Adjusted EPS of $0.26 Up 13 Percent GeneSight ® Demonstrates Statistical Significance for Response and Remission in Prospective Study SALT LAKE [...]
miRagen Therapeutics to Participate in Four Investor Conferences in November
07/11/2017
BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ) a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]
TESARO Announces Third-Quarter 2017 Operating Results
07/11/2017
ZEJULA ® was the most prescribed PARP inhibitor in U.S. with Q3 net sales of $39.4 million Positive CHMP opinion issued for ZEJULA in E.U.; commercial launch anticipated to begin by year-end Expansion of niraparib [...]
BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results
07/11/2017
Company Posts Strong Growth with Integration Ahead of Schedule Reports Record Quarterly Revenue and Adjusted EBITDA MALVERN, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile [...]
Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update
07/11/2017
Net cash used in operating and investing activities was $18.3 million in the third quarter and $94.8 million for the first nine months of 2017; quarter-end cash and restricted cash position of $460.1 million, provides [...]
TRACON Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
07/11/2017
SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Bellicum Reports Third Quarter 2017 Financial Results
07/11/2017
HOUSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Pages